tradingkey.logo

Bio Rad Laboratories Inc

BIO
294.825USD
-6.675-2.21%
收盘 02/09, 16:00美东报价延迟15分钟
8.33B总市值
亏损市盈率 TTM

Bio Rad Laboratories Inc

294.825
-6.675-2.21%

关于 Bio Rad Laboratories Inc 公司

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Bio Rad Laboratories Inc简介

公司代码BIO
公司名称Bio Rad Laboratories Inc
上市日期Mar 17, 1980
CEOSchwartz (Norman D)
员工数量7700
证券类型Ordinary Share
年结日Mar 17
公司地址1000 Alfred Nobel Dr
城市HERCULES
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编94547
电话15107247000
网址https://www.bio-rad.com/
公司代码BIO
上市日期Mar 17, 1980
CEOSchwartz (Norman D)

Bio Rad Laboratories Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+951364.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+1071.00%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+709.00%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+739.00%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+308.00%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+493.00%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
+308.00%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
+308.00%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Edward Chung
Mr. Edward Chung
Vice President - Investor Relations
Vice President - Investor Relations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+951364.00%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+1071.00%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+709.00%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+739.00%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+308.00%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+493.00%

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
270.00M
41.35%
EMEA
222.20M
34.03%
APAC
121.00M
18.53%
Other
39.80M
6.09%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 2月2日 周一
更新时间: 2月2日 周一
持股股东
股东类型
持股股东
持股股东
占比
First Eagle Investment Management, L.L.C.
11.50%
Alice N. Schwartz Revocable Trust
8.13%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
6.77%
Schwartz (Norman D)
6.36%
其他
59.15%
持股股东
持股股东
占比
First Eagle Investment Management, L.L.C.
11.50%
Alice N. Schwartz Revocable Trust
8.13%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
6.77%
Schwartz (Norman D)
6.36%
其他
59.15%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
45.18%
Investment Advisor
40.02%
Individual Investor
8.25%
Corporation
8.13%
Hedge Fund
5.13%
Research Firm
1.16%
Pension Fund
1.12%
Bank and Trust
0.96%
Sovereign Wealth Fund
0.63%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
1056
20.64M
94.21%
-1.79M
2025Q3
1095
20.58M
103.17%
+603.60K
2025Q2
1114
19.81M
108.02%
-855.27K
2025Q1
1146
19.96M
99.31%
-2.83M
2024Q4
1140
19.39M
101.48%
-657.49K
2024Q3
1121
20.03M
101.42%
-386.71K
2024Q2
1139
20.32M
91.46%
+1.29M
2024Q1
1154
19.07M
91.02%
-2.25M
2023Q4
1187
19.09M
89.28%
-259.69K
2023Q3
1170
19.31M
88.28%
-552.69K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
First Eagle Investment Management, L.L.C.
2.52M
11.5%
+3.01K
+0.12%
Sep 30, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.13%
--
--
Sep 25, 2025
The Vanguard Group, Inc.
1.79M
8.17%
-53.01K
-2.88%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.48M
6.77%
-61.47K
-3.98%
Sep 30, 2025
Schwartz (Norman D)
1.39M
6.36%
+951.36K
+214.86%
Sep 25, 2025
Dimensional Fund Advisors, L.P.
1.06M
4.85%
+63.37K
+6.34%
Sep 30, 2025
Veritas Asset Management LLP
844.04K
3.85%
-19.10K
-2.21%
Sep 30, 2025
Ariel Investments, LLC
809.48K
3.7%
-9.14K
-1.12%
Sep 30, 2025
EARNEST Partners, LLC
609.28K
2.78%
+3.40K
+0.56%
Sep 30, 2025
State Street Investment Management (US)
571.60K
2.61%
-12.77K
-2.18%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Parnassus Value Select ETF
3.94%
First Trust Indxx Medical Devices ETF
2.15%
ROBO Global Healthcare Technology & Innovation ETF
1.61%
Schwab Ariel Opportunities ETF
1.6%
First Trust Health Care Alphadex Fund
1.49%
FPA Global Equity ETF
1.38%
First Eagle Global Equity ETF
1.21%
iShares Health Innovation Active ETF
1.17%
Pacer US Export Leaders ETF
1.03%
Harbor Health Care ETF
0.82%
查看更多
Parnassus Value Select ETF
占比3.94%
First Trust Indxx Medical Devices ETF
占比2.15%
ROBO Global Healthcare Technology & Innovation ETF
占比1.61%
Schwab Ariel Opportunities ETF
占比1.6%
First Trust Health Care Alphadex Fund
占比1.49%
FPA Global Equity ETF
占比1.38%
First Eagle Global Equity ETF
占比1.21%
iShares Health Innovation Active ETF
占比1.17%
Pacer US Export Leaders ETF
占比1.03%
Harbor Health Care ETF
占比0.82%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI